Financhill
Back

Zacks Small/Mid Cap ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
64

SMIZ
Zacks Small/Mid Cap ETF

Last Price:
$38.20
Seasonality Move:
5.76%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.61
Seasonality Move:
-34.19%
Buy
64
Zacks Small/Mid Cap ETF (SMIZ) is a Buy

Is Zacks Small/Mid Cap ETF a Buy, Sell or Hold?

  • The current Zacks Small/Mid Cap ETF [SMIZ] share price is $38.20. The Score for SMIZ is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • SMIZ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.69. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SMIZ Stock Price Chart

What is Zacks Small/Mid Cap ETF's stock price today?

  • The Zacks Small/Mid Cap ETF share price today is $38.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMIZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.

SMIZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.42 Buy
Relative Strength Index (14 RSI): 58.02 Buy
Chaikin Money Flow: -6963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.55 Buy
Relative Strength Index (14 RSI): 70.17 Buy
Chaikin Money Flow: -284110 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.64 - 66.86) Buy
Bollinger Bands (100): (17.09 - 46.21) Buy

SMIZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.85 Buy
20-day SMA: 37.72 Buy
50-day SMA: 37.28 Buy
200-day SMA: 34.39 Buy
8-day EMA: 24 Buy
20-day EMA: 12.47 Buy
50-day EMA: 5.59 Buy
200-day EMA: 1.48 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.76 Buy
20-day SMA: 54.7 Buy
50-day SMA: 41.07 Buy
200-day SMA: 26.34 Buy
8-day EMA: 65.27 Buy
20-day EMA: 57.2 Buy
50-day EMA: 45.22 Buy
200-day EMA: 31.64 Buy

Zacks Small/Mid Cap ETF Earnings Growth & SMIZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Zacks Small/Mid Cap ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):